← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:1063 | 1063 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-114 | 73702-114-03 | Norepinephrine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1063 | 1063 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-9 | Neostigmine Methylsulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1063 | 1063 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1063 | 1063 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1063 | 1063 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0104 | 83863-0104-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1063 | 1063 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-122 | 73702-122-03 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1063 | 1063 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-166 | 82396-166-01 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1064 | 1064 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-156 | 82396-156-25 | Morphine Sulfate | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1064 | 1064 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1064 | 1064 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2422 | 72627-2422-1 | Methylcobalamin | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1064 | 1064 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3121 | 62295-3121-7 | Methylprednisolone Acetate; Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1064 | 1064 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1064 | 1064 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1064 | 1064 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1246 | 5446-1246-01 | Methacholine Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1064 | 1064 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6043 | 72196-6043-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1064 | 1064 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6039 | 72196-6039-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1064 | 1064 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-500 | 71170-500-25 | Norepinephrine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1064 | 1064 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-53 | Neostigmine Methylsulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1064 | 1064 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1064 | 1064 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1064 | 1064 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1064 | 1064 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-112 | 73177-112-03 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1064 | 1064 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6092 | 72196-6092-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1065 | 1065 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6078 | 71285-6078-1 | Vancomycin 2gm added to NS | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1065 | 1065 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1065 | 1065 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1065 | 1065 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3122 | 62295-3122-7 | Methylprednisolone Acetate; Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1065 | 1065 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1065 | 1065 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1065 | 1065 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1249 | 5446-1249-01 | Methacholine Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1065 | 1065 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6044 | 72196-6044-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1065 | 1065 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6042 | 72196-6042-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1065 | 1065 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-550 | 71170-550-25 | Norepinephrine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1065 | 1065 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-15 | Neostigmine Methylsulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1065 | 1065 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1065 | 1065 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1065 | 1065 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9022 | 71266-9022-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1065 | 1065 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-112 | 73177-112-05 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1065 | 1065 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-115 | 73177-115-03 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1066 | 1066 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5605 | 26436-5605-3 | TESTOSTERONE 20% | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1066 | 1066 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Salicylic Acid; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1066 | 1066 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2421 | 72627-2421-1 | Methylcobalamin | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1066 | 1066 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0624 | 71283-0624-1 | Methylprednisolone; Bupivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1066 | 1066 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1066 | 1066 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1066 | 1066 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1247 | 5446-1247-01 | Methacholine Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1066 | 1066 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8069 | 72196-8069-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1066 | 1066 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6043 | 72196-6043-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1066 | 1066 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5040 | 70214-5040-1 | Norepinephrine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1066 | 1066 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:1066 | 1066 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1066 | 1066 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1066 | 1066 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-174 | 63037-174-25 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1066 | 1066 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:1066 | 1066 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-124 | 73702-124-10 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1067 | 1067 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0001 | 71285-0001-1 | Microplegia (MSA/MSG 0.91 Molar) 125ml Bag | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1067 | 1067 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Salicylic Acid; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1067 | 1067 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1067 | 1067 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metoclopramide | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1067 | 1067 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1067 | 1067 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methazolamide | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1067 | 1067 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1067 | 1067 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0012 | 71139-0012-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1067 | 1067 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-028 | 71506-028-59 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1067 | 1067 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-552 | 70324-552-01 | Norepinephrine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1067 | 1067 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0329 | 60652-0329-1 | Neostigmine Methylsulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1067 | 1067 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1067 | 1067 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1067 | 1067 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-173 | 63037-173-25 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1067 | 1067 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9022 | 71266-9022-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1067 | 1067 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9031 | 71266-9031-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1068 | 1068 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0649 | 26436-0649-3 | Carnitine 250mg/mL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1068 | 1068 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Salicylic Acid; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1068 | 1068 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1068 | 1068 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1068 | 1068 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 51754-9130 | 51754-9130-1 | Midazolam Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1068 | 1068 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methimazole | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1068 | 1068 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1068 | 1068 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-068 | 70092-068-07 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1068 | 1068 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6031 | 72196-6031-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1068 | 1068 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-702 | 70324-702-01 | Norepinephrine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1068 | 1068 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-002 | 72055-002-01 | Neostigmine Methylsulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1068 | 1068 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1068 | 1068 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1068 | 1068 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1068 | 1068 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:1068 | 1068 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6009 | 72196-6009-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1069 | 1069 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-023 | 71506-023-03 | Glycopyrrolate | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1069 | 1069 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1069 | 1069 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5239 | 26436-5239-8 | Methylcobalamin | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1069 | 1069 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1069 | 1069 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 51754-9131 | 51754-9131-5 | Midazolam Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1069 | 1069 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-567 | 72833-567-30 | Methionine; Choline Chloride; Inositol; Cyanocobalamin; Benzyl Alcohol | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1069 | 1069 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1069 | 1069 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6044 | 71285-6044-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1069 | 1069 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6036 | 72196-6036-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1069 | 1069 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-577 | 70324-577-01 | Norepinephrine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1069 | 1069 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:1069 | 1069 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1069 | 1069 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1069 | 1069 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1069 | 1069 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6092 | 72196-6092-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1069 | 1069 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6007 | 72196-6007-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1070 | 1070 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1070 | 1070 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1070 | 1070 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5354 | 26436-5354-1 | Methylene Blue | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1070 | 1070 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1070 | 1070 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5234 | 26436-5234-3 | Minoxidil; Tretinoin; Finasteride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1070 | 1070 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Inositol; Choline Chloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1070 | 1070 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methazolamide | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1070 | 1070 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8069 | 71285-8069-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1070 | 1070 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6044 | 72196-6044-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1070 | 1070 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-602 | 70324-602-01 | Norepinephrine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1070 | 1070 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:1070 | 1070 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5580 | 26436-5580-1 | Phenol | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1070 | 1070 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9030 | 71266-9030-1 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1070 | 1070 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-978 | 69194-978-10 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1070 | 1070 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-166 | 73177-166-05 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1070 | 1070 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5230 | 71266-5230-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1071 | 1071 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1318 | 61141-1318-1 | Fentanyl Citrate 2500mcg/250mL (10mcg/mL) bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1071 | 1071 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1071 | 1071 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3119 | 62295-3119-1 | Methylprednisolone Acetate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1071 | 1071 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1071 | 1071 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Mirtazapine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1071 | 1071 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Inositol; Succinylcholine Chloride; Cyanocobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1071 | 1071 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methimazole | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1071 | 1071 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6043 | 71285-6043-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1071 | 1071 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8069 | 72196-8069-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1071 | 1071 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1071 | 1071 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:1071 | 1071 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6519 | 71266-6519-1 | Phenol | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1071 | 1071 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9011 | 71266-9011-9 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1071 | 1071 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-980 | 69194-980-10 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1071 | 1071 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-166 | 73177-166-25 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1071 | 1071 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9010 | 71266-9010-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1072 | 1072 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9030 | 71266-9030-1 | Phenylephrine HCl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1072 | 1072 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1072 | 1072 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1065 | 71266-1065-1 | Methylprednisolone Acetate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1072 | 1072 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1072 | 1072 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1009 | 5446-1009-01 | Mitomycin | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1072 | 1072 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Inositol; Succinylcholine Chloride; Cyanocobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1072 | 1072 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-567 | 72833-567-30 | Methionine; Choline Chloride; Inositol; Cyanocobalamin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1072 | 1072 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-543 | 69374-543-50 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1072 | 1072 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1072 | 1072 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-032 | 71506-032-58 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1072 | 1072 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5066 | 26436-5066-3 | Niacinamide | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1072 | 1072 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1072 | 1072 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9011 | 71266-9011-1 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1072 | 1072 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-979 | 69194-979-10 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1072 | 1072 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-115 | 73177-115-03 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1072 | 1072 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9010 | 71266-9010-9 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1073 | 1073 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-348 | 69194-348-01 | 348 VANCOMYCIN 1MG/0.1ML VIAL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1073 | 1073 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1073 | 1073 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-5 | Methylprednisolone Acetate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1073 | 1073 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1073 | 1073 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1416 | 5446-1416-01 | Mitomycin | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1073 | 1073 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methocarbamol | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1073 | 1073 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Inositol; Choline Chloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1073 | 1073 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6031 | 71285-6031-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1073 | 1073 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-012 | 68985-012-93 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1073 | 1073 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1073 | 1073 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2414 | 72934-2414-2 | Niacinamide; Azelaic Acid | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1073 | 1073 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1073 | 1073 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1073 | 1073 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-974 | 69194-974-10 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1073 | 1073 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:1073 | 1073 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9010 | 71266-9010-2 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1074 | 1074 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-602 | 81375-602-01 | Lidocaine Phenylephrine | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1074 | 1074 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1074 | 1074 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1074 | 1074 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3340 | 62295-3340-7 | Midazolam | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1074 | 1074 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6412 | 71266-6412-2 | Mitomycin | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1074 | 1074 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methohexital Sodium | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1074 | 1074 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methocarbamol | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1074 | 1074 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6032 | 71285-6032-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1074 | 1074 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-004 | 72055-004-01 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1074 | 1074 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1074 | 1074 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2395 | 72934-2395-2 | Niacinamide; Calcipotriene | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1074 | 1074 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1074 | 1074 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1074 | 1074 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1074 | 1074 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9031 | 71266-9031-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1074 | 1074 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6092 | 71285-6092-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1075 | 1075 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 54288-840 | 54288-840-25 | Tirzepatide and Pyridoxine Hydrochloride Injection, 30 mg/3 mL (10 mg/mL) and 30 mg/3 mL (10 mg/mL) | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1075 | 1075 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1075 | 1075 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1075 | 1075 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3341 | 62295-3341-2 | Midazolam | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1075 | 1075 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8475 | 71266-8475-1 | Mitomycin | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1075 | 1075 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1505 | 5446-1505-01 | Methotrexate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1075 | 1075 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methohexital Sodium | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1075 | 1075 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6036 | 71285-6036-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1075 | 1075 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0903 | 60652-0903-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1075 | 1075 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-474 | 76154-474-15 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1075 | 1075 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-3303 | 72934-3303-0 | Niacinamide; Clindamycin Phosphate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1075 | 1075 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1075 | 1075 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1075 | 1075 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1075 | 1075 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-124 | 73702-124-10 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1075 | 1075 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-123 | 73702-123-10 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1076 | 1076 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0015 | 73271-0015-1 | ESTRADIOL 15 PEL | 2025-1 | valid | 0 | 2026-09-18 |